DENVER − The story of the bioresorbable coronary artery stent is far from over, but three-year data from the Absorb III study of the Absorb GT1 by Abbott Park, Ill.-based Abbott Vascular suggests that vessel size matters, but isn't everything where scaffold thrombosis is concerned. Read More
